截至2025年末，公司总资产为466,455.48万元，较期初增长2.32%；归属于上市公司股东的所有者权益为377,573.73万元，较期初增长 2.82%；归属于上市公司股东的每股净资产为2.57元，较期初增长2.80%。公告显示，公司财务状况持续优化，主要系公司净利润增加所致。 | | | | 甲例: 力兀 | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | 增减变动幅度 | | | | | (%) | | 营业总收入 | 227,776.35 | 209,830.14 | 8.55% | | 营业利润 | 23,143.17 | 19.631.84 | 17.89% | | 利润总额 | 23.433.83 | 19.455.58 | 20.45% | | 归属于上市公司股东的净利润 | 18.341.53 | 16.348.82 | 12.19% | | 扣除非经常性损益后的归属于上市 | 17.052.85 | 13.472.8 | 26.57% | | 公司股东的净利润 | | | | | 基本每股收益(元/股) | 0.1265 | 0.1112 ...

Core Viewpoint - The company expects a net profit of 42 million to 50 million yuan for the fiscal year 2025, representing a year-on-year growth of 50.30% to 78.93% [1] Financial Performance - The expected net profit after deducting non-recurring gains and losses is projected to be between 28.8 million and 36.8 million yuan, indicating a year-on-year increase of 106.01% to 163.23% [1] - The overall consolidated operating revenue for 2025 is anticipated to decline by approximately 10% year-on-year, while the gross profit margin remains stable [1] Business Operations - The company maintains stable operations in its dual main businesses of fabric weaving and medical devices [1] - In the automotive interior fabric sector, the company is actively developing new customers and solidifying its market position [1] - The apparel fabric business has been significantly impacted by external market conditions, leading to a decrease in operating revenue [1]

Group 1: Company Research and Development - The company has its own research center and collaborates extensively with external universities and research institutions [1] - Currently, the solid-state battery membrane is in the small-scale sample delivery phase, with no mass production or substantial sales yet [1] Group 2: Product Applications and Market Focus - The company's products are based on ultra-fine fiber technology, focusing on industrial fabric applications [1] - The company is optimistic about future growth, particularly in sportswear fabrics, automotive interior fabrics, and electronic product fabrics [2] Group 3: Product Development and Commercialization - Samples of bio-inspired muscle fibers are available, and the company is conducting applied research with leading robotics manufacturers, but no mass production or revenue has been generated yet [2] - The company has been testing hydrogen separation membrane samples since last year and aims to expedite the commercialization process [2] Group 4: Financial Strategy and Future Plans - The company will formulate future funding plans based on its needs, especially after a major shareholder transferred equity to an industry partner [2]